Ambulatory mammography

Series
Diagnostic imaging
Status
Ongoing
Date
Number of report
068

Ask the expert

(we accept only company emails)

The report presents a summary of reimbursement situation for mammography in ambulatory settings.

All procedure codes for different types of mammography will be provided in the analysis.

When fee for service payment model is used, all fees for available reimbursement codes will be provided.

When DRG payment model is used, reimbursement analysis will cover the following indications:

  • mammography in malignant neoplasm of breast
  • mammography in benign breast lesions

The only reimbursement within public / statutory health insurance systems is considered.

Policy analysis will include reimbursement decisions and health technology assessments mammography as diagnostic and screening method.

Report includes essential information about reimbursement and national funding, including:

  • Brief overview of reimbursement system for medical devices
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions in indications or scenarios for use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Denmark
  • England (UK)
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Sweden
  • Switzerland

Manufacturers of equipment for ambulatory mammography include:

  • ADANI (Mammoscan)
  • Analogic Corporation (Digital Mammography)
  • ANKE (ASR-4000, ASR-3000)
  • Aurora (Aurora)
  • Allengers Medical (Fairy DR, Fairy, Venus)
  • BMI Biomedical International (Milady)
  • Canon (Artemis)
  • Carestream Health (Digital Mammography)
  • Delphinus Medical Technologies (SoftVue)
  • DMS-IMAGING (Serenys)
  • ECORAY (EXR-650)
  • Fujifilm (AMULET Innovality, AMULET, AMULET f / AMULET s)
  • GE Healthcare (Senographe Pristina)
  • General Medical Merate (Viola)
  • GENORAY (DMX-600, MX-600)
  • GMI General Medical (Lambda)
  • Hologic (3Dimensions, Selenia Dimensions)
  • IMS (GIOTTO CLASS, GIOTTO IMAGE)
  • ITALRAY (Mammograph, Mammograph FFDM)
  • Konica Minolta (Digital Mammography)
  • Landwind Medical (Luna)
  • MS Westfalia (GAIA)
  • Metaltronica (Helianthus C)
  • Micrima (Maria)
  • NP JSC AMICO (Mammo-RPd, MAMMO-RP)
  • Panacea Medical (Lilac)
  • Perlove Medical (BTX-9800B, BTX-9800D, MEGA600)
  • Philips Healthcare (MicroDose SI)
  • Planmed (Planmed Clarity 3D, Planmed Clarity 2D, Planmed Sophie Classic S)
  • Radmir (Syma, Madis)
  • Shenzhen Angell Technology (Mammography-DM 158)
  • Siemens Healthcare (Mammomat Revelation, Mammomat Inspiration, Mammomat Fusion, Mammomat Select)
  • SternMed (Xenox)
  • Villa Sistemi Medicali (Melody III, Melody IIID, Melody IID TS)

Table of content is not available at the moment. Report is still ongoing.

15

May 2019

The HTA center of Swedish Västra Götaland region has published a report, which aimed to evaluate the effectiveness of EEG-based neurofeedback as a treatment for post-traumatic stress disorder (PTSD). It is uncertain whether the procedure compared with no or standard treatment reduces PTSD symptoms in adult patients. It is also uncertain whether the treatment results in any difference in suicidal thoughts, level of functioning, or medication use.

Read more

21

Dec 2018

Changes will be made in sixteen chapters of Nomenclature. In relation to medical technologies and in-vitro diagnostics, the most important changes include creation of new codes for ophthalmology, otorhinolaryngology, radiology, radiotherapy and nuclear medicine, clinical biology and genetic examinations.

Read more

26

Oct 2018

In October 2018, the Austrian HTA body, the Ludwig-Boltzmann Institue (LBI), published the update on the PET/PET-CT topic. The report was done together with the Berlin Technical University.

Read more

28

Jun 2018

At the beginning of June 2018, the Andalusian agency for health technology evaluation, AETSA, has published a meta-analysis on digital tomosynthesis in breast cancer.

Read more

07

Jun 2018

In May of 2018, the Federal Joint Committee (G-BA) approved two additional indications for application of PET/CT for management of malignant lymphomas for coverage within statutory health insurance. As the procedures were included into Directive for methods and examinations and Directive methods of the contract medical care, they are now reimbursed in both hospital and out-patient settings.

Read more

03

Oct 2017

New procedure codes will be created for stem cell procedures, extracorporeal techniques (including hemodialysis and CO2 removal), surgical interventions, including growth-controlling spinal correction, transposition of peripheral nerve, interventions on veins, and percutaneous image-guided procedures (including code for pressure measurement in coronary arteries and additional code for drug-eluting balloon). Classification will be enabled from January 1, 2018.

Read more

16

Jun 2017

In March 2017, G-BA approved two additional indications for application of PET/CT for management of neck and head tumors in hospital settings after reevaluation of evidence by IQWiG in 2016. New indications concern decision making about need for neck dissection and laryngoscopic biopsy.

Read more
(we accept only company emails)